Corgi Genomics & Precision Medicine ETF (GNMX) price, chart and fund profile
Price chart
Fund profile
GNMX seeks capital appreciation.
- Issuer
- Corgi Strategies, LLC
- Industry
- Theme
- Inception
- May 6, 2026
- Expense ratio
- 0.35%
- Net asset value
- $36.27
- NAV as of
- Aug 27, 2026
- Leverage
- 1×
- Fund page
- www.corgifunds.com↗
Frequently asked questions
What is Corgi Genomics & Precision Medicine ETF (GNMX)?
GNMX seeks capital appreciation.
What is GNMX's expense ratio?
Corgi Genomics & Precision Medicine ETF charges an annual expense ratio of 0.35%. The fund is issued by Corgi Strategies, LLC.
How large is GNMX?
Corgi Genomics & Precision Medicine ETF manages $1.9M in assets and has traded since May 6, 2026.
How do I buy shares of Corgi Genomics & Precision Medicine ETF (GNMX)?
GNMX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.